These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12207814)

  • 1. The evaluation of screening policies for diabetic retinopathy using simulation.
    Davies R; Roderick P; Canning C; Brailsford S
    Diabet Med; 2002 Sep; 19(9):762-70. PubMed ID: 12207814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme.
    Younis N; Broadbent DM; Harding SP; Vora JP
    Diabet Med; 2003 Sep; 20(9):758-65. PubMed ID: 12925058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for diabetic retinopathy in James Bay, Ontario: a cost-effectiveness analysis.
    Maberley D; Walker H; Koushik A; Cruess A
    CMAJ; 2003 Jan; 168(2):160-4. PubMed ID: 12538543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening intervals for diabetic retinopathy and incidence of visual loss: a systematic review.
    Echouffo-Tcheugui JB; Ali MK; Roglic G; Hayward RA; Narayan KM
    Diabet Med; 2013 Nov; 30(11):1272-92. PubMed ID: 23819487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a district-wide screening programme for diabetic retinopathy utilizing trained optometrists using slit-lamp and Volk lenses.
    Hulme SA; Tin-U A; Hardy KJ; Joyce PW
    Diabet Med; 2002 Sep; 19(9):741-5. PubMed ID: 12207810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of optometry vs digital photography screening for diabetic retinopathy in a single district.
    Tu KL; Palimar P; Sen S; Mathew P; Khaleeli A
    Eye (Lond); 2004 Jan; 18(1):3-8. PubMed ID: 14707956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool Diabetic Eye Study.
    Harding SP; Broadbent DM; Neoh C; White MC; Vora J
    BMJ; 1995 Oct; 311(7013):1131-5. PubMed ID: 7580708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-utility of telemedicine to screen for diabetic retinopathy in India.
    Rachapelle S; Legood R; Alavi Y; Lindfield R; Sharma T; Kuper H; Polack S
    Ophthalmology; 2013 Mar; 120(3):566-573. PubMed ID: 23211635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting and treating retinopathy in patients with type I diabetes mellitus. A health policy model.
    Javitt JC; Canner JK; Frank RG; Steinwachs DM; Sommer A
    Ophthalmology; 1990 Apr; 97(4):483-94; discussion 494-5. PubMed ID: 2109299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simulation of diabetic eye disease to compare screening policies.
    Davies R; Sullivan P; Canning C
    Br J Ophthalmol; 1996 Nov; 80(11):945-50. PubMed ID: 8976719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory photographic screening for diabetic retinopathy in nursing homes.
    Anderson S; Broadbent DM; Swain JY; Vora JP; Harding SP
    Eye (Lond); 2003 Aug; 17(6):711-6. PubMed ID: 12928682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for diabetic retinopathy in a clinical setting: a comparison of direct ophthalmoscopy by primary care physicians with fundus photography.
    Griffith SP; Freeman WL; Shaw CJ; Mitchell WH; Olden CR; Figgs LD; Kinyoun JL; Underwood DL; Will JC
    J Fam Pract; 1993 Jul; 37(1):49-56. PubMed ID: 8345340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for diabetic retinopathy: a relative cost-effectiveness analysis of alternative modalities and strategies.
    Sculpher MJ; Buxton MJ; Ferguson BA; Spiegelhalter DJ; Kirby AJ
    Health Econ; 1992 Apr; 1(1):39-51. PubMed ID: 1342628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study.
    Younis N; Broadbent DM; Vora JP; Harding SP;
    Lancet; 2003 Jan; 361(9353):195-200. PubMed ID: 12547541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for sight-threatening diabetic retinopathy: comparison of fundus photography with automated color contrast threshold test.
    Ong GL; Ripley LG; Newsom RS; Cooper M; Casswell AG
    Am J Ophthalmol; 2004 Mar; 137(3):445-52. PubMed ID: 15013866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of detecting and treating diabetic retinopathy.
    Javitt JC; Aiello LP
    Ann Intern Med; 1996 Jan; 124(1 Pt 2):164-9. PubMed ID: 8554212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of strategies for detecting diabetic retinopathy.
    Dasbach EJ; Fryback DG; Newcomb PA; Klein R; Klein BE
    Med Care; 1991 Jan; 29(1):20-39. PubMed ID: 1898753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing ongoing quality assurance in a retinal screening programme.
    Arun CS; Young D; Batey D; Shotton M; Mitchie D; Stannard KP; Taylor R
    Diabet Med; 2006 Jun; 23(6):629-34. PubMed ID: 16759304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Issues regarding quality assurance in the English National Screening Programme for Sight-threatening Diabetic Retinopathy: response to paper by C. Arun et al., 'Establishing ongoing quality assurance in a retinal screening programme'.
    Garvican L
    Diabet Med; 2007 Jun; 24(6):688-90; author reply 690-1. PubMed ID: 17523969
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-utility analysis of screening for diabetic retinopathy in Japan: a probabilistic Markov modeling study.
    Kawasaki R; Akune Y; Hiratsuka Y; Fukuhara S; Yamada M
    Ophthalmic Epidemiol; 2015 Feb; 22(1):4-12. PubMed ID: 25517603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.